ABNB vs ABUS · P/E 29, rev $12.24B vs P/E 5.4, rev $6.2M
Airbnb Inc (ABNB) versus Arbutus Biopharma Corp (ABUS) — a side-by-side from cached financials, not a winner call.
Airbnb Inc (ABNB) is a travel services company listed on US. It is led by Brian Chesky.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Latest reported ABNB revenue for 2025-12-31 was $12.24B. Net income was $2.51B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. ABNB currently screens at market cap $72.43B and trailing P/E 28.7.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
ABNB currently screens at market cap $72.43B and trailing P/E 28.7. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Not investment advice. Open the ABNB and ABUS stock pages for the full models.
Not investment advice.